- Home
- DNA vs CLPT Comparison
DNA vs CLPT Comparison
Compare DNA & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNA | CLPT |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.3M | 494.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DNA | CLPT |
|---|---|---|
| Price | $9.65 | $14.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $10.50 | ★ $27.67 |
| AVG Volume (30 Days) | ★ 950.4K | 635.3K |
| Earning Date | 02-24-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,606,000.00 | $34,332,000.00 |
| Revenue This Year | N/A | $18.93 |
| Revenue Next Year | $3.07 | $51.64 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $5.00 | $9.76 |
| 52 Week High | $17.58 | $30.10 |
Technical Indicators
Market Signals| Indicator | DNA | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 56.16 | 49.28 |
| Support Level | $9.39 | $13.80 |
| Resistance Level | $10.00 | $16.58 |
| Average True Range (ATR) | 0.50 | 1.01 |
| MACD | 0.14 | 0.11 |
| Stochastic Oscillator | 65.60 | 37.34 |
Price Performance
Historical ComparisonAbout DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.